Table 3 Characteristics of admitted patients with COVID-19
Variable | COVID-19 admitted patients n = 6 |
|---|---|
Women, n (%) | 5 (83.33) |
Age, median (IQR), years | 14.5 (4–16) |
Diagnosis, n (%) | |
Systemic JIA | 1 (16.6) |
Oligoarticular JIA with associated uveitis | 2 (28.8) |
Systemic lupus erythematosus | 1 (16.6) |
Vasculitis | 1 (16.6) |
Autoinflammatory syndrome | 1 (16.6) |
COVID-19–related treatments during admission, n (%) | |
Hydroxychloroquine | 1 (16.6) |
Glucocorticoids | 2 (28.8) |
Azithromycin | 1 (16.6) |
Lopinavir/ritonavir | 1 (16.6) |
Admission duration, median (IQR), (days) | 5 (2–15) |